A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses
ABSTRACTWorld Health Organization has declared the ongoing outbreak of coronavirus disease 2019 (COVID-19) a Public Health Emergency of International Concern. The virus was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the International Committee on Taxonomy of Viruses. Human...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | Emerging Microbes and Infections |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2020.1736644 |
_version_ | 1797265846161113088 |
---|---|
author | Sin-Yee Fung Kit-San Yuen Zi-Wei Ye Chi-Ping Chan Dong-Yan Jin |
author_facet | Sin-Yee Fung Kit-San Yuen Zi-Wei Ye Chi-Ping Chan Dong-Yan Jin |
author_sort | Sin-Yee Fung |
collection | DOAJ |
description | ABSTRACTWorld Health Organization has declared the ongoing outbreak of coronavirus disease 2019 (COVID-19) a Public Health Emergency of International Concern. The virus was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the International Committee on Taxonomy of Viruses. Human infection with SARS-CoV-2 leads to a wide range of clinical manifestations ranging from asymptomatic, mild, moderate to severe. The severe cases present with pneumonia, which can progress to acute respiratory distress syndrome. The outbreak provides an opportunity for real-time tracking of an animal coronavirus that has just crossed species barrier to infect humans. The outcome of SARS-CoV-2 infection is largely determined by virus-host interaction. Here, we review the discovery, zoonotic origin, animal hosts, transmissibility and pathogenicity of SARS-CoV-2 in relation to its interplay with host antiviral defense. A comparison with SARS-CoV, Middle East respiratory syndrome coronavirus, community-acquired human coronaviruses and other pathogenic viruses including human immunodeficiency viruses is made. We summarize current understanding of the induction of a proinflammatory cytokine storm by other highly pathogenic human coronaviruses, their adaptation to humans and their usurpation of the cell death programmes. Important questions concerning the interaction between SARS-CoV-2 and host antiviral defence, including asymptomatic and presymptomatic virus shedding, are also discussed. |
first_indexed | 2024-03-07T17:24:46Z |
format | Article |
id | doaj.art-0dfda238a33d4012bbb4fd8bb3bc3d45 |
institution | Directory Open Access Journal |
issn | 2222-1751 |
language | English |
last_indexed | 2024-04-25T00:51:17Z |
publishDate | 2020-01-01 |
publisher | Taylor & Francis Group |
record_format | Article |
series | Emerging Microbes and Infections |
spelling | doaj.art-0dfda238a33d4012bbb4fd8bb3bc3d452024-03-11T16:04:23ZengTaylor & Francis GroupEmerging Microbes and Infections2222-17512020-01-019155857010.1080/22221751.2020.1736644A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic virusesSin-Yee Fung0Kit-San Yuen1Zi-Wei Ye2Chi-Ping Chan3Dong-Yan Jin4School of Biomedical Sciences, The University of Hong Kong, Pokfulam, Hong KongSchool of Biomedical Sciences, The University of Hong Kong, Pokfulam, Hong KongDepartment of Microbiology, The University of Hong Kong, Pokfulam, Hong KongSchool of Biomedical Sciences, The University of Hong Kong, Pokfulam, Hong KongSchool of Biomedical Sciences, The University of Hong Kong, Pokfulam, Hong KongABSTRACTWorld Health Organization has declared the ongoing outbreak of coronavirus disease 2019 (COVID-19) a Public Health Emergency of International Concern. The virus was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the International Committee on Taxonomy of Viruses. Human infection with SARS-CoV-2 leads to a wide range of clinical manifestations ranging from asymptomatic, mild, moderate to severe. The severe cases present with pneumonia, which can progress to acute respiratory distress syndrome. The outbreak provides an opportunity for real-time tracking of an animal coronavirus that has just crossed species barrier to infect humans. The outcome of SARS-CoV-2 infection is largely determined by virus-host interaction. Here, we review the discovery, zoonotic origin, animal hosts, transmissibility and pathogenicity of SARS-CoV-2 in relation to its interplay with host antiviral defense. A comparison with SARS-CoV, Middle East respiratory syndrome coronavirus, community-acquired human coronaviruses and other pathogenic viruses including human immunodeficiency viruses is made. We summarize current understanding of the induction of a proinflammatory cytokine storm by other highly pathogenic human coronaviruses, their adaptation to humans and their usurpation of the cell death programmes. Important questions concerning the interaction between SARS-CoV-2 and host antiviral defence, including asymptomatic and presymptomatic virus shedding, are also discussed.https://www.tandfonline.com/doi/10.1080/22221751.2020.1736644CoronavirusSARS-CoVSARS-CoV-2COVID-192019 novel coronavirushost antiviral response |
spellingShingle | Sin-Yee Fung Kit-San Yuen Zi-Wei Ye Chi-Ping Chan Dong-Yan Jin A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses Emerging Microbes and Infections Coronavirus SARS-CoV SARS-CoV-2 COVID-19 2019 novel coronavirus host antiviral response |
title | A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses |
title_full | A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses |
title_fullStr | A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses |
title_full_unstemmed | A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses |
title_short | A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses |
title_sort | tug of war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence lessons from other pathogenic viruses |
topic | Coronavirus SARS-CoV SARS-CoV-2 COVID-19 2019 novel coronavirus host antiviral response |
url | https://www.tandfonline.com/doi/10.1080/22221751.2020.1736644 |
work_keys_str_mv | AT sinyeefung atugofwarbetweensevereacuterespiratorysyndromecoronavirus2andhostantiviraldefencelessonsfromotherpathogenicviruses AT kitsanyuen atugofwarbetweensevereacuterespiratorysyndromecoronavirus2andhostantiviraldefencelessonsfromotherpathogenicviruses AT ziweiye atugofwarbetweensevereacuterespiratorysyndromecoronavirus2andhostantiviraldefencelessonsfromotherpathogenicviruses AT chipingchan atugofwarbetweensevereacuterespiratorysyndromecoronavirus2andhostantiviraldefencelessonsfromotherpathogenicviruses AT dongyanjin atugofwarbetweensevereacuterespiratorysyndromecoronavirus2andhostantiviraldefencelessonsfromotherpathogenicviruses AT sinyeefung tugofwarbetweensevereacuterespiratorysyndromecoronavirus2andhostantiviraldefencelessonsfromotherpathogenicviruses AT kitsanyuen tugofwarbetweensevereacuterespiratorysyndromecoronavirus2andhostantiviraldefencelessonsfromotherpathogenicviruses AT ziweiye tugofwarbetweensevereacuterespiratorysyndromecoronavirus2andhostantiviraldefencelessonsfromotherpathogenicviruses AT chipingchan tugofwarbetweensevereacuterespiratorysyndromecoronavirus2andhostantiviraldefencelessonsfromotherpathogenicviruses AT dongyanjin tugofwarbetweensevereacuterespiratorysyndromecoronavirus2andhostantiviraldefencelessonsfromotherpathogenicviruses |